Voices
Stephen V Liu: Real World Results on Neoadjuvant Chemoimmunotherapy for Early Stage NSCLC Clinical Lung
Stephen Liu/X

Stephen V Liu: Real World Results on Neoadjuvant Chemoimmunotherapy for Early Stage NSCLC Clinical Lung

Stephen V Liu, Director of Thoracic Oncology, Chief of the Division of Hematology and Oncology, and Associate Professor at Georgetown Lombardi Comprehensive Cancer Center, shared a post on shared a post on X:

“Real world results from Alberta, Canada on neoadjuvant chemoimmunotherapy for early stage NSCLC Clinical Lung similar to trials:

  • 86% underwent surgery
  • pCR rate 30%
  • Nearly all pts achieving R0 resection
  • 13% relapsed (none of whom achieved MPR).”
Title: Brief Report: An Observational Population Level Study Of Neoadjuvant Chemoimmunotherapy for Resectable Non-Small Cell Lung Cancer

Authors: Siddhartha Goutam, Amanda JW Gibson, Michelle Liane Dean, Abigail R Miller, Bianca Rosin de Oliveira, Vishal Navani.

Read the article

Stephen V Liu

Other articles about NSCLC on OncoDaily.

Abigail R Miller Alberta Amanda JW Gibson Bianca Rosin de Oliveira Canada cancer Michelle Liane Dean OncoDaily Oncology Siddhartha Goutam Stephen V Liu Vishal Navani